These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18976315)

  • 1. Intravitreal silicone oil droplets following pegaptanib injection.
    Kocabora MS; Ozbilen KT; Serefoglu K
    Acta Ophthalmol; 2010 Mar; 88(2):e44-5. PubMed ID: 18976315
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal silicone oil droplets after intravitreal drug injections.
    Bakri SJ; Ekdawi NS
    Retina; 2008; 28(7):996-1001. PubMed ID: 18698303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicone oil droplets following intravitreal injection.
    Freund KB; Laud K; Eandi CM; Spaide RF
    Retina; 2006; 26(6):701-3. PubMed ID: 16829818
    [No Abstract]   [Full Text] [Related]  

  • 4. Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration.
    Williams AJ; Fekrat S
    Am J Ophthalmol; 2006 Oct; 142(4):683-4. PubMed ID: 17011868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Study of Silicone Oil Microdroplets in Eyes Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in 3 Different Syringes.
    Thompson JT
    Ophthalmol Retina; 2021 Mar; 5(3):234-240. PubMed ID: 32735904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic vitreitis outbreak after intravitreal injection.
    Deka S
    Retina; 2011 Mar; 31(3):631; author reply 631. PubMed ID: 21336079
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks.
    Molina Guilabert I; Calvo-González C; Reche-Frutos J; Donate-López J; García-Feijoó J; Leila M; García-Sánchez J
    Acta Ophthalmol; 2009 Aug; 87(5):581-2. PubMed ID: 18937799
    [No Abstract]   [Full Text] [Related]  

  • 8. The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy.
    Ghajarnia M; Kurup S; Eller A
    Semin Ophthalmol; 2007; 22(2):127-31. PubMed ID: 17564935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic safety of bilateral intravitreal anti-vascular endothelial growth factor injections.
    Freund KB; Vance SK
    Retina; 2011 Jan; 31(1):1-3. PubMed ID: 21187729
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
    Criswell MH; Hu WZ; Steffens TJ; Li R; Margaron P
    Arch Ophthalmol; 2008 Jul; 126(7):946-52. PubMed ID: 18625941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPE tears after pegaptanib treatment in age-related macular degeneration.
    Chang LK; Flaxel CJ; Lauer AK; Sarraf D
    Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silicone oil droplets after intravitreal bevacizumab injection in two patients.
    Caroca JO; Caroca JIO
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jun; 95(6):e43. PubMed ID: 32376125
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
    Khurana RN; Chang LK; Porco TC
    JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib].
    Maier M; Feucht N; Huebner M; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab local complications.
    Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
    Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G
    Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitreous injections of pegaptanib sodium triggering allergic reactions.
    Steffensmeier AC; Azar AE; Fuller JJ; Muller BA; Russell SR
    Am J Ophthalmol; 2007 Mar; 143(3):512-3. PubMed ID: 17317399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence.
    Uparkar M; Maiti A; Natarajan S
    Retina; 2008 Mar; 28(3):527; author reply 527-8. PubMed ID: 18327151
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.